Fideuram Intesa Sanpaolo Private Banking S.P.A. Purchases Shares of 113,081 Oscar Health, Inc. $OSCR

Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR) in the first quarter, according to its most recent filing with the SEC. The firm purchased 113,081 shares of the company’s stock, valued at approximately $1,297,000.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in Oscar Health by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after purchasing an additional 540,851 shares during the period. Geode Capital Management LLC lifted its stake in Oscar Health by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after buying an additional 116,430 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in Oscar Health by 1,097.8% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock valued at $3,418,000 after buying an additional 218,022 shares during the period. BIT Capital GmbH boosted its holdings in shares of Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after buying an additional 5,227,152 shares in the last quarter. Finally, Farallon Capital Management LLC boosted its holdings in shares of Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after buying an additional 2,163,000 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

Oscar Health Price Performance

Shares of OSCR opened at $32.09 on Friday. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.10. The business’s fifty day moving average is $24.49 and its 200 day moving average is $17.87. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock has a market cap of $9.67 billion, a P/E ratio of -54.38, a P/E/G ratio of 2.25 and a beta of 2.34.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. Oscar Health’s revenue was up 52.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.92 EPS. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on OSCR. UBS Group raised their price objective on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Wells Fargo & Company set a $20.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Barclays raised shares of Oscar Health from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $30.00 to $35.00 in a research note on Wednesday, June 10th. Robert W. Baird raised their price target on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.78.

Insider Buying and Selling at Oscar Health

In other news, CFO Richard Scott Blackley sold 100,000 shares of the business’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the completion of the sale, the chief financial officer directly owned 1,216,660 shares of the company’s stock, valued at $28,177,845.60. The trade was a 7.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark T. Bertolini bought 1,000,000 shares of the stock in a transaction that occurred on Monday, April 6th. The stock was acquired at an average price of $11.92 per share, for a total transaction of $11,920,000.00. Following the acquisition, the chief executive officer directly owned 10,196,876 shares in the company, valued at $121,546,761.92. The trade was a 10.87% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders have sold 3,662,466 shares of company stock valued at $105,145,815. Corporate insiders own 24.39% of the company’s stock.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.